Parkin (PARK 2) Mutations Are Rare in Czech Patients with Early-Onset Parkinson's Disease

Ondrej Fiala; Daniela Zahorakova; Lenka Pospisilova; Jana Kucerova; Milada Matejckova; Pavel Martasek; Jan Roth; Evzen Ruzicka

doi:10.1371/journal.pone.0107585

Loading metrics

Open Access

Peer-reviewed

Research Article

Parkin (PARK 2) Mutations Are Rare in Czech Patients with Early-Onset Parkinson's Disease

Ondrej Fiala ,

* E-mail: fiala@inep.cz

Affiliations Department of Neurology and Centre of Clinical Neuroscience, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic, Institute of Neuropsychiatric Care (INEP), Prague, Czech Republic
⨯
Daniela Zahorakova,

Affiliation Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, and General University Hospital, Charles University, Prague, Czech Republic
⨯
Lenka Pospisilova,

Affiliation Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, and General University Hospital, Charles University, Prague, Czech Republic
⨯
Jana Kucerova,

Affiliation Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, and General University Hospital, Charles University, Prague, Czech Republic
⨯
Milada Matejckova,

Affiliation Department of Pathology and Molecular Medicine, Thomayer's University Hospital, Prague, Czech Republic
⨯
Pavel Martasek,

Affiliation Department of Pediatrics and Adolescent Medicine, 1st Faculty of Medicine, and General University Hospital, Charles University, Prague, Czech Republic
⨯
Jan Roth,

Affiliation Department of Neurology and Centre of Clinical Neuroscience, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic
⨯
Evzen Ruzicka

Affiliation Department of Neurology and Centre of Clinical Neuroscience, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic
⨯

Parkin (PARK 2) Mutations Are Rare in Czech Patients with Early-Onset Parkinson's Disease

Ondrej Fiala,
Daniela Zahorakova,
Lenka Pospisilova,
Jana Kucerova,
Milada Matejckova,
Pavel Martasek,
Jan Roth,
Evzen Ruzicka

Published: September 19, 2014
https://doi.org/10.1371/journal.pone.0107585

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Point mutation
Is the Subject Area "Point mutation" applicable to this article?

Thanks for your feedback.
Heterozygosity
Is the Subject Area "Heterozygosity" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Parkinson disease
Is the Subject Area "Parkinson disease" applicable to this article?

Thanks for your feedback.
Dopaminergics
Is the Subject Area "Dopaminergics" applicable to this article?

Thanks for your feedback.
Homozygosity
Is the Subject Area "Homozygosity" applicable to this article?

Thanks for your feedback.
Czech people
Is the Subject Area "Czech people" applicable to this article?

Thanks for your feedback.
Mutation
Is the Subject Area "Mutation" applicable to this article?

Thanks for your feedback.